• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • Industry News
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
    • Hemp State Regulatory Agencies
  • Newsletters
    • CBE Week
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
    • Marijuana
    • Hemp
  • Contact
  • AB Survey
  • About Us
  • Account
  • Accounting Services
  • Advertise
  • Advertising, PR & Marketing
  • All Cannabis News
  • Ancillary Business Survey 2018
  • Ancillary Business Survey 2019
  • Archived Webinars
  • Associations & Organizations
  • Banking & Payment Processing
  • Better Start for the Glass Ceiling in this Industry, CBE’s Most Influential Women
  • Book Reviews
  • Business Directory
  • Business Directory Introduction
  • Business Directory Listing
  • Business Directory Manage
  • Business Directory Registration Info
  • Business Directory Welcome
  • Call for speakers
  • Cannabis Investments
  • Cart
  • CBE Exchange
  • CBE HotLists
    • CBE Lab Testing Services HotList 2014
  • CBE Lists
  • CBE Political 50
  • CBE Press LLC Privacy Statement
  • CBE Press News
  • Checkout
  • Consulting Services
  • Consumption Gear
  • Contact
  • Contribute
  • Contributors
  • Create Your Product & Service Press Release
  • Creative Submission
  • Cultivation Products & Services
  • Current Poll
  • Edible & Infused Products
  • Editor’s Page
  • Email Whitelisting Instructions
  • Event Listing Questionaire
  • Featured Videos
  • Funding Options
  • Hemp State Regulatory List
  • Home
  • Human Capital Management Newsletters
  • Industry Jobs
  • Join the CBE Business Directory
  • Join the Directory
  • Lab Testing Regulations
  • Lab Testing Services
  • Login
  • Logout
  • Marijuana State Regulatory Contacts
  • Marijuana Tax Facts
  • Media Kit
  • Medical Marijuana Qualifying Conditions
  • Members
  • MJ Media Kit
  • Most Popular Stories
  • Most Read Stories
  • New Product & Service Listings Welcome
  • News Releases
  • Newsletters
    • Ask CBE
    • CBE Human Capital Management
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
    • CBE Technology & Solutions
    • CBE Week
  • On the Move
  • Organizations & Associations
  • Packaging & Supplies
  • Password Reset
  • Policy & Legal
  • PPR Survey
  • Product Releases
  • Profile Update
  • Register
  • Security Solutions
  • Software & Technology
  • Sponsored Polls
  • State Cannabis Product Packaging Requirements
  • Terms of Service
  • Thank You
  • The Most Influential People in the Cannabis Industry, The Cannabis Business Executive 100
  • Training & Educational Services
  • Upcoming Webinars
  • User
  • Whitepapers
  • WV Senate passes medical marijuana bill to House
  • Categories
  • Locations
  • My Bookings
You are here: Home / Best Practices / The End of Zero Tolerance? Drafting Workable Substance Abuse Policies in a Legal Cannabis Climate

The End of Zero Tolerance? Drafting Workable Substance Abuse Policies in a Legal Cannabis Climate

June 29, 2016 by Darren Weiss Leave a Comment

Employers across the nation have long incorporated into their workplace policies a statement providing that their offices, job sites, and factories are “drug free” and that they take a “zero tolerance” approach to the use of drugs.

The zero tolerance movement has enjoyed considerable popularity in the past 40 years, even meeting with official sanction from the U.S. government in its Drug Free Workplace Act of 1988. These policies have closely followed, and found encouragement from, the war-on-drugs culture so predominant in our society since the same was articulated by Richard Nixon in the 1970s.

But times, as they say, are a-changing.

In the past 10 years, we have seen a profound increase in the use and abuse of prescription opiates, along with an attendant increase in heroin addiction. At the same time, and for not altogether unrelated reasons, we have seen a paradigm shift in the way in which cannabis has been viewed from a legal perspective. Today, all but seven (7) states, and a host of localities, have in place legislation either decriminalizing or actually permitting the use of cannabis (or its derivatives) for medical and/or adult use (or “recreational”) purposes.

Notwithstanding this momentous shift, cannabis remains absolutely illegal according to the Federal government, maintaining its position as a Schedule I substance. We are left with a landscape in which worker productivity can very well be far more damaged by the use of legal, prescribed narcotics than substances which the federal government deems completely and totally illegal.

In light of these recent developments, drafting a workable substance abuse policy is perhaps more difficult today than ever. Employers must ensure the safety and protection of their workforce, customers, and property; however, they are also increasingly expected to provide working environments which accommodate rather than punish. The result is that the tried and true Zero Tolerance Policy may no longer be appropriate — even if it may still in some jurisdictions be legal.

Let’s be clear about several things, however. If your business has federal contracts over $100,000 or is a federal grantee of any kind, it will be subject to the federal Drug Free Workplace Act and must comply with the provisions of that law. Moreover, if your employees are drivers, pilots, or involved in other “safety sensitive” jobs under the aegis of the federal Department of Transportation, the Omnibus Transportation Employee Testing Act of 1991 also requires strict drug testing.

Additionally, as both a cannabis and a management-side employment attorney, I do not advocate for acceptance in the workplace of dangerous behaviors associated with being high, drunk, or under the influence of any substance — whether lawfully prescribed or otherwise. Employers have an obligation, both legal and moral, to ensure that their workplaces are safe. Permitting the use of intoxicating substances during the work day, or the behavior associated with intoxication, is neither advisable nor appropriate.

But what about the employee who uses cannabis on his or her own time where such use neither interferes with nor impacts their work? Does it matter if the employee uses cannabis pursuant to a doctor’s certification and obtains the product from a legal, licensed dispensary? Or what if the employee uses the cannabis for “adult-use” or “recreational” purposes in a state where the same is permitted? Although an employer is often permitted to prohibit such conduct, is it wise to do so?

Whether or not an employer is situated in a medical cannabis State, employers must still contend with the Americans with Disabilities Act. Under that law, discrimination against an employee having, or perceived as having, a disability is rendered illegal. The ADA requires employers to provide disabled employees a reasonable accommodation to permit them to perform the essential functions of their jobs.

The conundrum employers face is that many, if not all, of the conditions considered “qualifying” in medical cannabis states are also disabilities under the ADA. Although the use of medical cannabis may not be a required or contemplated accommodation under the ADA (since the federal government prohibits any use of cannabis), it may be reasonable under state law equivalents or a pragmatic way to maintain an excellent employee notwithstanding her or his treatment and use of cannabis.

Moreover, the Federal Equal Employment Opportunity Commission has made clear in the past that it will pursue claims where employees are terminated for the use of medical cannabis if there is evidence supporting the conclusion that the reason underlying the termination is the employee’s disability. Workers’ compensation laws may also be implicated, although with respect to workplace accidents most such laws permit an employer to dispute claims where the employee was intoxicated or impaired.

A necessary addition to this mix is the fact that many of the new medical cannabis states expressly forbid discrimination based on the use of medical cannabis. Arizona, Connecticut, Delaware, Maine, Minnesota, Nevada, Pennsylvania, and Rhode Island, among others, all prohibit refusing to hire, penalizing, or firing an employee for their use of medical cannabis or their status as a cannabis patient, or terminating an employee as a result of a positive drug test for off-duty cannabis use.

As such, there are currently states in which a zero tolerance policy is actually illegal under state law. Paradoxically, however, many states with legal medical cannabis programs actually require drug-free workplaces for its licensed cannabis businesses.

Given the current status of the law, what is a responsible employer to do?

The first step is to ascertain whether a federal law or prevailing safety concern requires your business to maintain a drug-free workplace policy and/or mandatory drug testing. If no such law applies, it may be advisable to work with your employment attorney to draft a workplace substance abuse policy which aims to target and punish unacceptable behaviors rather than a positive drug screen. Of course, there may still be drugs which you do not want anywhere near your workplace (e.g., cocaine, methamphetamine, LSD), but with respect to substances such as cannabis, it may be advisable to incorporate a more nuanced policy.

Your substance abuse policy should directly address — and forbid — behaviors which pose a safety risk to your staff, clientele, and property; it should also be drafted in such a way to ensure that worker productivity remains optimal. But your business may very well be best served by softening your “zero tolerance” stance to permit the lawful use of substances such as cannabis. In other words, “zero tolerance” may be a relic of the past.

Filed Under: Best Practices, Policy & Legal Tagged With: Americans with Disabilities Act, Darren Weiss, Drug Free Workplace Act of 1988, Federal Equal Employment Opportunity Commission, Substance Abuse Policies, Zero Tolerance

About Darren Weiss

A frequent author and speaker on legal issues affecting the legalized cannabis industry, Darren H. Weiss is a cannabis industry thought leader and a seasoned business counselor. A passionate and experienced legal advocate, Mr. Weiss’s practice focuses primarily on cannabis and corporate law, including formation and organization of cannabis companies; corporate financing; drafting and negotiating investment documents, licensing agreements, and vendor contracts; and providing business advice and counsel on competitive licensing applications and cannabusiness design and strategy. Mr. Weiss has been counsel to both investors and cannabis businesses and has helped close multi-million dollar transactions and provided counsel in the creation of multi-state brands and products.

Mr. Weiss, a co-founder of his law firm’s Cannabis Practice Group, built his practice representing clients in the financial services, medical care, manufacturing, and professional services industries, and has spent years working with businesses to maintain, preserve, and protect their most valuable assets. Mr. Weiss received his Bachelor’s Degree magna cum laude from Washington University in St. Louis and his Juris Doctorate cum laude from George Mason University School of Law. During law school Mr. Weiss served as Executive Editor on the George Mason Law Review, participated in Moot Court and Trial Advocacy, and had the opportunity to intern on both trial and appellate courts. Prior to law school, Mr. Weiss worked at a business intelligence software company where he consulted on enterprise wide performance management initiatives for public- and private-sector clients and taught workshops on software and business integration.

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Business Development Officer - Specialty Ag - Bank Michigan - Ann Arbor, MI
  • Field Applications Support Scientist - Danaher - Framingham, MA
  • Flash Chromatography Applications Chemist - VRS Recruitment - , NY

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Industry Blogs



Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2020 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·